Genetic and amino acid analysis of the GL protein of Canadian, American and European equine arteritis virus isolates.

The genetic variation in equine arteritis virus (EAV) GL protein encoding gene was investigated. Nucleic and deduced amino acid sequences from 7 different EAV isolates, including 4 eastern Canadian field isolates, were compared with those of the Bucyrus reference strain. Nucleotide sequence identities between these isolates and the Bucyrus reference strain ranged from 87.5% (Vienna isolate) to 93.9% (11958 isolate). Amino acid identities with the Bucyrus reference strain varied from 90.2% (Vienna isolate) to 95.1% (19933 isolate). A 2nd potential N-linked glycosylation site was found at position 81 in the GL protein of all EAV isolates. Three amino acid substitutions at residue position 90 (Glu-->Val), position 101 (Ala-->Val or Thr), and position 119 (Val-->Leu, Phe or Ser) were also found in all EAV isolates. Phylogenetic analysis showed that the North American EAV isolates, including the Canadian isolates, and the European prototype Vienna isolate could be classified in 2 distinct groups. Three putative sequential antigenic sites were predicted in EAV GL protein. The 1st antigenic site (TAQRFT) was located at positions 24 to 29, and the 2nd antigenic site (RYDEHTA) at positions 47 to 53. The 3rd antigenic site was predicted to be located at positions 78 to 84 and showed the less conserved amino acid sequence.     

猪δ冠状病毒西安株M基因序列的信息分析

为研究猪δ冠状病毒(PDCoV)西安株M基因的遗传特征,以分离并鉴定的PDCoV西安株(CHN-XA18-35株)为材料,根据GenBank中已发表的PDCoV M基因保守序列设计引物,经RT-PCR扩增PDCoV西安株M全基因序列并测序,应用生物信息学方法对M基因进行分析。结果显示,CHN-XA18-35株M基因序列与其他地区PDCoV参考株的核苷酸同源性为98.47%~99.54%,推导的氨基酸序列同源性为97.24%~99.08%;CHN-XA18-35株与其他地区PDCoV参考株相比,M蛋白第189位氨基酸由异亮氨酸(IIe)突变为精氨酸(Arg);CHN-XA18-35株M蛋白的10-27、34-56、66-87位氨基酸属于跨膜区;跨膜区氨基酸多为疏水性氨基酸,且存在α-螺旋;潜在的B细胞抗原表位位于M蛋白的102-107 aa(LSPESR)、149-158 aa(NGISVRNPPQ)、200-209 aa(LHTITTSKAG)。结果表明,CHN-XA18-35株M蛋白第189位氨基酸发生了突变,其B细胞抗原表位与其他PDCoV株相比未发生改变。     

Cytopathogenicity markers in the genome of Hungarian cytopathic isolates of bovine viral diarrhoea virus

Since genetic recombination is a major factor in the evolution of the cytopathogenic (cp) bovine viral diarrhoea virus (BVDV) biotypes, in this study the cytopathogenicity markers were investigated in the genomes of two cp BVDV strains recently isolated from mucosal disease (MD) cases in Hungary. In the genome of strain H4956, a Jiv-like insertion was found similar to those described in reference strain NADL and in other BVDV 1, BVDV 2 and border disease virus (BDV) strains. The 133 amino acid Jiv-like sequence is inserted at nucleotide position 4984 (amino acid position 1533), 9 nucleotides upstream of that of strain NADL. The insertion showed 96% amino acid sequence identity with the cellular Jiv protein. In the genome of cp BVDV strain H115/PCR, an ubiquitin-containing duplication was found. The duplicated sequence started at nucleotide position 7978 (amino acid 2531) in the NS4B gene. The duplication contained a complete ubiquitin monomer of 76 amino acids and the complete NS3 gene starting at nucleotide position 5153 (amino acid 1589), which corresponds to the first N-terminal amino acid of NS3. The duplication was located further downstream of the known ubiquitin-containing genomic regions of cp BVDV strains, and it consisted of the shortest inserted nucleotide sequence. The insertions and duplication of strains H4956 and H115/PCR further confirmed that recombinations occurring at positions A and B are the most common mechanisms leading to the development of BVDV cytopathogenicity.     

犬瘟热病毒N基因和M基因的克隆与序列分析

以从宠物临床上分离的犬瘟热病毒(canine distemper virus,CDV)总RNA为模板,根据GenBank中已报道的CDV核蛋白（N）、基质膜蛋白（M）基因序列,分别设计合成1对特异性引物,RT-PCR扩增N、M蛋白编码基因,并进行克隆与序列分析。结果显示,均扩增出预期大小的片段。扩增片段经核苷酸序列分析,N、M编码基因全长分别为1572、1008 bp,该CDV的N蛋白编码基因序列与Onderstepoort疫苗株、A75/17株的同源性分别为93.9%、97.6%,编码氨基酸的同源性分别为96.9%、98.7%;M蛋白编码基因序列与Onderstepoort疫苗株、A75/17株的同源性分别为94.5%、97.8%,编码氨基酸的同源性分别为97.9%、99.7%,这说明N、M蛋白均是保守性较强的结构蛋白,且同强毒株A75/17的亲缘关系要比Onderstepoort疫苗株更近。     

Effect of L-carnitine supplementation on utilisation of energy and protein in broiler chicken fed different dietary fat levels.

Effects of a supplementation of 80 mg L-carnitine per kg diet were studied in broiler chicken at two dietary levels of fat (4 and 8%) and different feeding levels (ad libitum in a growth trial, 95 and 85% of ad libitum in a balance trial). A low-carnitine basal diet adequate in amino acid concentration was used. In the growth trial, each diet was fed to 9 groups of 10 birds each for 16 days from day 5 of live onwards. Growth and feed intake were determined. At the end of the trial, birds were killed and homogenised for subsequent empty body analysis. Accretion of protein and energy was determined using a representative blank group killed at the beginning of the trial. In the balance trial, 8 individual birds were used per treatment. Birds were offered the feed at approximately 85 and 95% of ad libitum intake, which was determined with separate birds for both fat levels. Excreta were quantitatively collected three times daily for 8 consecutive days beginning on day 17 individually for each bird. Supplemented L-carnitine did not significantly affect any response criterion. However, growth and feed conversion tended to be improved by about 5% in the carnitine supplemented diets when fed ad libitum. An interaction between carnitine and fat level occurred with regard to feed conversion, indicating that carnitine had a positive effect at the high fat level, but not at the low fat level. L-carnitine did not positively affect the metabolisability of energy (ME/GE) and the efficiency of energy utilisation (RE/GE or RE/ME). Similarly, no significant carnitine effect was determined with regard to N accretion and the efficiency of utilisation of dietary protein in both trials. It is concluded that endogenous carnitine synthesis is not the limiting factor for energy utilisation in broiler chicken, even at high dietary fat concentration. Occasionally reported positive effects of supplemental carnitine were likewise caused by reasons other than improved energy or protein utilisation. Further studies on amino acid utilisation and catabolism should consider marginal amino acid supply.     

Relatedness of cytotoxins from geographically diverse isolates of Moraxella bovis

To determine whether amino acid sequence variation exists in the Moraxella bovis (M. bovis) cytotoxin (MbxA) from geographically diverse M. bovis isolated in the United States, mbxA was amplified and sequenced. The MbxA deduced amino acid sequence from M. bovis originally isolated in California, Washington, North Carolina, and Georgia, as well as reference strains of M. bovis isolated at the National Animal Disease Laboratory, Ames, IA, USA, all encoded a nearly identical 927 amino acid protein. MbxA from two of the four California isolates (SFS 9a and SFS 100a) differed from all other isolates at two sites at which the polar amino acids glutamine (position 666) and asparagine (position 823) were replaced by ionized amino acids glutamic acid and aspartic acid, respectively. Rabbit antiserum to the expressed carboxy terminus (amino acids 590-927) of MbxA from M. bovis (Tifton I) neutralized the hemolytic activity of SFS 9a and SFS 100a. The M. bovis cytotoxin appears to be conserved amongst geographically diverse isolates of M. bovis from the USA. Antiserum against the carboxy terminus of MbxA common to the majority of isolates neutralized the hemolytic activity of two strains with a divergent MbxA deduced amino acid sequence. Vaccines against IBK that incorporate MbxA as antigen may offer protection against geographically diverse strains of M. bovis.     

DNA sequence analysis of glycoprotein G gene of bovine ephemeral fever virus and development of a double oil emulsion vaccine against bovine ephemeral fever

The surface glycoprotein G is considered as the major neutralizing and protective antigen of bovine ephemeral fever virus (BEFV). Comparison of the deduced amino acid sequence of G protein of BEFV isolates during the period 1984-2004 outbreaks in Taiwan showed amino acid substitutions in the neutralizing epitopes. All the isolates differ markedly in the neutralizing epitope at the same amino acid positions compared to the currently available killed vaccine strain (Tn73). Tn88128 strain isolated in 1999 showed the maximum variability of 12 amino acids, 5 amino acid in the neutralization epitope and 7 apart from, respectively. Combinations of both Tn88128 (1999) and commercially available vaccine strain (Tn73) were developed and its safety was evaluated in mice, guinea pigs, calves, and pregnant cows. None of the animals showed any adverse effect or clinical signs. Calves were immunized with commercial vaccine (Tn73) and, combined vaccine (Tn73 and Tn88128), respectively, with adjuvants such as Al-gel and water-in-oil-in-water (w/o/w) oil and PBS alone and challenged with Tn88128 strains. Except PBS administered animals, all the vaccinated animals showed protective immune response. However, animals immunized with combined vaccine plus w/o/w adjuvant elicited stronger neutralization antibodies and long lasting immunity compared to other vaccines.     

犬瘟热病毒上海分离株M蛋白编码基因的克隆与序列分析

本研究以犬瘟热病毒(canine distemper virus,CDV)上海分离株的总RNA为模板,根据GenBank中已报道的CDV M蛋白基因序列,设计合成1对特异性引物,RT PCR扩增M蛋白基因,并进行克隆与序列分析。结果显示,CDV上海分离株M蛋白基因序列与CDV A75/17 株、Onderstepoort疫苗株等其它7株的同源性在95%以上;编码氨基酸的同源性也高于97%。推测M蛋白是一个保守性非常强的结构蛋白。     

犬冠状病毒JS1706和JS1712毒株基因组3'端分子特性分析

为了全面了解犬冠状病毒（CCoV）分离毒株JS1706和JS1712基因组3'端主要结构蛋白基因和非结构蛋白基因的分子特征,本研究设计了8组引物进行RT-PCR扩增,产物经测序和拼接后,获得了约8.7 kb基因组片段,该基因组结构及其编码蛋白顺序为5'-S-3abc-E-M-N-7ab-3'。对CCoV JS1706、JS1712株8.7 kb基因组核苷酸序列与α冠状病毒属参考毒株的相同区域核苷酸序列进行比对,结果表明,2个分离株与CCoV Ⅱ型参考毒株相似性最高（83.4%~93.1%）,其次为FCoV Ⅱ型参考毒株（87.1%~87.9%）、TGEV参考毒株（86.1%~86.8%）、CCoV Ⅰ型参考毒株（72.0%~72.1%）和FCoV Ⅰ型参考毒株（67.5%~69.9%）。JS1706、JS1712毒株与同属冠状病毒参考株的结构蛋白S、E、M和N蛋白氨基酸相似性分别为46.4%~95.2%、75.6%~100%、82.8%~99.2%和78.5%~99.7%。说明同属内冠状病毒的S基因变异度大,E、M、N基因相对保守。根据基因组3'端8.7 kb核苷酸序列和S蛋白氨基酸序列相似性比对结果,JS1706和JS1712毒株均与泛嗜型原型株CB/05相似性最高,分别为93.0%~93.1%、94.8%~95.2%,其他结构蛋白包括E、M和N氨基酸序列比对也发现与CB/05株的相似性较高,分别为97.6%~100%、92.4%~93.1%和97.9%。S蛋白氨基酸序列的进一步分析表明,JS1706和JS1712毒株的S蛋白N端有一些特有氨基酸,S蛋白氨基酸序列中没有明显的S1/S2蛋白酶切位点（RRARR）,但在958—963位氨基酸有S2'裂解位点特征基序（KRKYRS）。基于S蛋白氨基酸序列构建的系统发育进化树分析显示,CCoV JS1706和JS1712株与CCoV Ⅱa亚型参考毒株和FCoV Ⅱ型参考毒株聚集形成一个分枝。CCoV JS1706和JS1712株非结构蛋白的编码基因ORF3abc和ORF7,其结构、大小与经典疫苗株INSAVC-1相似,无明显插入、缺失和移码突变。本研究有助于深入了解国内CCoV流行毒株的分子特性,为后续分子流行病学调查、诊断试剂和疫苗研发奠定了基础。     

Ⅰa型牛源无乳链球菌M7菌株Sip基因的分子特征分析

通过PCR方法扩增Ⅰa型牛源无乳链球菌地方菌株M7的Sip基因,将目的片段克隆入pGEM-T Easy载体并进行测序,采用多种生物软件对Sip基因及其表达的蛋白质进行分子特征分析。试验结果表明,M7菌株的Sip基因为1305 bp,未出现基因缺失;与GenBank中发表的不同血清型的无乳链球菌菌株的相应核苷酸序列同源性为98.0%~100.0%,推导的氨基酸同源性为97.2%~99.8%。M7的Sip基因与中国菌株Ly2(FJ808732)和美国菌株GB00549(FJ752159)的相应基因的核苷酸同源性和氨基酸同源性最高,核苷酸同源性均为100.0%,氨基酸同源性均为99.8%。该Sip基因表达的蛋白质是一种稳定的分泌性外膜蛋白,疏水性强;其N-末端的第52-95位氨基酸残基之间含有1个LysM超家族的保守结构域;存在1-25位氨基酸的信号肽,剪切位点在第25-26位氨基酸之间;存在多个B细胞和T细胞表位。说明M7菌株的Sip基因是未缺失LysM超家族结构域的比较保守的免疫蛋白。     

国产IBV疫苗株核衣壳蛋白基因的亲缘关系

利用自行设计的引物Cx和Cs，通过RT－PCR方法分别扩增出鸡传染性支气管炎病毒（IBV）D41株，H120GD株、H120SH株、H52GD株等4个国产疫苗株和标准强毒M41－E4株完整的N基因cDNA,然后将其分别克隆到pGEM T-Easy或pMD 18-T载体中并测序。测序结果表明，这5个IBV毒株可分2组，其中D41株，H120GD株和H120SH株为一组，它们的核苷酸和推导氨基酸序列同源性为99．7％－99．8％和99．0％－99．5％，而H52GD株与M41－E4株构成另一组，其核苷酸和推导氨基酸序列同源性为99．7％和99．5％；而2组之间的最大同源性仅为91．0％和93．2％。在系统发生进化树上，这2组分别位于不同的分支簇上。值得注意的是，国内的H52GD株与国外报道的H52株不在同一分支簇上，相反却与国内强毒M41－E4株以及国外报道的M41株在同一分支簇上。这一结果表明，国内的H52GD疫苗株与国外报道的H52疫苗株不同，它们在亲缘关系上更靠近M41－E4株和M41株。     

Production and characterization of two Streptococcus suis capsular type 2 mutants.

Two avirulent mutants of Streptococcus suis capsular type 2 (M2 and M42) were produced from a highly virulent strain. Mutant M2, obtained after serial subcultures of the parent strain in the presence of rabbit anti-capsular type 2 serum, no longer possessed the type-specific capsular antigen, as demonstrated by serotyping methods and immunoelectron microscopy. The Lancefield group D antigen could not be detected on the cell surface of this mutant using the immunogold labelling technique. SDS-PAGE of lysozyme treated cells demonstrated that a 44 kDa protein which was present in the parent strain, was absent in mutant M2. Immunoblotting using rabbit whole cell homologous anti-serum revealed that the protein was strongly immunogenic. Mutant M2 was totally avirulent in mice, and the homologous antiserum completely failed to protect mice against challenge with the parent strain. However, mutant M42, obtained after passages of the parent strain at 42 degrees C, remained capsulated but lacked the same 44 kDa protein as mutant M2. The quantity of sialic acid present in the capsule was similar to that of the parent strain. Despite the presence of antibodies against the capsule, antiserum prepared against M42 only partially protected mice against a challenge with the parent strain. The 44 kDa cell wall protein could act as a virulence factor as well as an important immunogen of S. suis capsular type 2.     

新城疫病毒TL1株M基因的克隆和序列分析

采用RT-PCR方法扩增了新城疫病毒(NDV)TL1株M基因,将扩增产物提纯后克隆入pGEM-T easy载体,通过酶切、PCR和测序验证克隆正确。测序拼接得出M基因的序列长度为1232 bp,该基因的ORF总长为1095 bp,编码364个氨基酸。与GenBank下载的15株参考毒株M基因比较,核苷酸同源性为85.2%~98.1%,编码的氨基酸同源性为85.8%~98.9%。NDV TL1产生M蛋白分子中有7对碱性氨基酸,5个保守的Cys残基,与鹅源新城疫SF02株、ZJ1株具有类似的特征。这些结果为揭示NDV TL1株的分子生物学背景,阐明NDV种间传播机制奠定了基础。     

Comparison of the characters of the plaque-purified viruses from foot-and-mouth disease virus O/JPN/2000

At least two biotypes were observed at the 2nd passage stage after the isolation of Foot-and-mouth disease Virus (FMDV) O/JPN/2000 strain. These 2 types of viruses differed from their plaque phenotypes and were distinguishable by using a monoclonal antibody (MAb) 64G8 that was made for the FMDV O/JPN/2000 strain. One of these 2 biotypes formed small plaque (SP) and with immuno staining showed a positive reaction to MAb 64G8, while the other formed clear large plaque (LP) and did not react with MAb 64G8. The amino acid sequences of the capsid coding region (VP1-VP4) of the SP virus (SPV) and the LP virus (LPV) revealed two substitutions on the 133rd amino acid in VP2, and the 56th amino acid in VP3. These amino acid changes of SPV and LPV are Asn to Asp, Arg to His, respectively. The Arg of the 56th amino acid in VP3 that have been known as critical position of cell culture adapted virus. Only LPV showed high pathogenicity in suckling mice, and its LD(50) was calculated to be about 10(2) TCID(50)/0.1 ml. These results showed that the SPV that existed at the 2nd passage stage from isolation was a low virulence virus, which may suggest why the pathogenicity of O/JPN/2000 did not show clear symptoms in infected cattle.     

UL46基因移码突变对PRV毒力的影响

伪狂犬病病毒(Pseudorabies virus,PRV)变异株(JS-2012株)在Vero细胞上40℃传代培养120代后,获得了1株弱毒株(JS-2012-F120株)。该毒株UL46基因3'端有29个碱基插入,导致了130个氨基酸突变。为了研究UL46基因移码突变对PRV生物学特性的影响,本研究用JS-2012-F120的ΔUL46基因替换了JS-2012的UL46基因,构建了重组病毒JS-2012-ΔUL46,并对该重组病毒、高温传代毒株(JS-2012-F120)及其亲本强毒株(JS-2012)在细胞上的生长特性和对小鼠的毒力进行了比较分析。结果显示,与亲本毒株(JS-2012)相比,传代毒株(JS-2012-F120)病毒滴度明显提高,对小鼠的毒力明显减弱;重组病毒(JS-2012-ΔUL46)在Vero细胞上的生长趋势没有明显改变,对小鼠的毒力减弱。因此,UL46基因移码突变对PRV在Vero细胞上的复制没有明显影响,但减弱了PRV对小鼠的毒力。     

Sequence analysis and expression of Nramp-1 gene in Bcgr and Bcgs mice.

Nucleic acid sequence of complemental DNA open reading frame for Nramp-1 gene was compared among DBA/2 (Bcgr), C57BL/6 (Bcgs) and C57BL/6-Bcgr mice which was previously developed as M. avium-resistant mouse strain (Xu, et al. Veterinary Microbiology 50:73-79 (1996). Total RNA was isolated from various organs of DBA/2, C57BL/6 and C57BL/6-Bcgr. Nramp-1 cDNA was constructed from their mRNAs by gene amplification (PCR) technique and their open reading frame sequences were compared. The results clearly showed that our C57BL/6-Bcgr was almost identical with the DNA sequence of the DBA/2 mice. In contrast, C57BL/6-Bcgs mice differed only on the substitution of adenine for guanine of the nucleic acid at position 596. This corresponded to the site of amino acid substitution (glycine to asparate) at position 169 in predicted NRAMP which had been reported. The expression of Nramp-1 mRNA was more prominent in spleens and livers and there appeared to be no significant difference among the strains of mice.     

犬瘟热病毒蓝狐分离株融合蛋白基因的序列分析

根据已发表的犬瘟热病毒(Canine distemper virus,CDV)Onderstepoort株序列设计1对引物,RT-PCR法扩增出约1 000 bp的融合蛋白基因片段,通过T-A克隆技术,将PCR产物克隆至pMD18-T载体。序列分析表明CDV蓝狐分离株F蛋白基因片段由1 044 bp组成,编码348个氨基酸,与其它CDV25259株、2544-Han95株、A75-17株、DOGDK91C株、5804P株、ONP株、PDV-2株核苷酸序列同源性分别为94.5%、94.1%、94.7%、94.2%、94.2%、97.6%和94.9%;氨基酸序列的同源性分别为98.6%、97.1%、98.0%、98.0%、98.3%、97.7%和98.6%;与其它CDV毒株相比,蓝狐分离株存在核苷酸缺失突变(1 030位～1 038位)和氨基酸缺失突变(344位～348位)。     

IBDV地方变异株VP2基因的克隆与特性鉴定

应用 RT- PCR技术对 1株分离于地方免疫鸡群中暴发的传染性法氏囊病病例的传染性法氏囊病病毒 ( infec-tious bursal disease virus,IBDV) HN0 2 6株的 VP2基因进行了克隆与序列分析 ,并与相应毒株的 VP2高变区核苷酸及氨基酸序列进行了比较研究。结果表明 ,HN0 2 6株的核苷酸和氨基酸序列与变异株 Var- A的同源性最高 ,分别达97.3%和 97.6 % ;其次为超强毒株 UK6 6 1 ,分别为 95 .7%和 95 .2 % ;而和弱毒株 PBG98的同源率仅有 92 .8%和90 .3%。其中 ,在第一、二亲水区 ,HN0 2 6株均有 1个氨基酸发生了变化 ,即第 2 2 2位转变为 E、第 31 8位转变为 D。更重要的是 ,其 2 4 9位和 2 5 4位上的氨基酸分别为 K和 S,这些均为变异株的特性。另外 ,HN0 2 6株的七肽区保持SWSASGS不变 ,且第 2 79位和 2 84位氨基酸分别为 D和 A,又完全具备强毒株的特性。因此 ,初步确定所分离的HN0 2 6为有较强致病力的变异株 IBDV。     

FliC蛋白R91S突变对肠炎沙门菌鞭毛形态和小鼠体内定植的影响

沙门菌血清D群3个血清型FliC蛋白氨基酸序列比对分析表明肠炎沙门菌与鸡伤寒沙门菌完全相同，二者与鸡白痢沙门菌存在第91位氨基酸位点差异。本研究旨在探究肠炎沙门菌FliC蛋白第91位精氨酸突变对鞭毛形态、细菌运动性和小鼠体内定植能力的影响。运用λ-Red同源重组技术删除肠炎沙门菌CICC10467 fliC基因，构建系列反式回补突变株，通过体外生长特性试验和Western blot试验分析各菌株生长和FliC蛋白表达情况，运动性试验分析各菌株在半固体琼脂中的泳动能力，电子显微镜观察各菌株鞭毛形态，细胞感染试验分析各菌株的细胞黏附和入侵能力，动物感染试验分析各菌株的组织侵染能力。结果表明，fliC基因缺失株及点突变回补株与野生株的体外生长能力无显著差异（P ≥ 0.05）。fliC基因缺失后肠炎沙门菌不表达鞭毛蛋白，各点突变回补株与野生株鞭毛蛋白表达量无明显差异。FliC蛋白R91S突变导致肠炎沙门菌鞭毛形态由超螺旋形态转变为钝直、柔韧度减弱，运动性显著降低（P<0.000 1），对RAW264.7和HCT116细胞的黏附入侵能力显著下降（P<0.001），对BALB/c小鼠的器官侵染能力显著减弱（P<0.001）。综上表明，FliC蛋白第91位精氨酸对维持细菌运动性至关重要，第91位精氨酸突变能够显著改变肠炎沙门菌鞭毛形态，减弱肠炎沙门菌在小鼠体内定植能力。     

TGEV的sM、M和N基因克隆及特征分析

参照(3enBank中收录的TGEV sM、M和N基因序列各设计1对特异引物，经RT-PCR扩增获得了TS株的相应基因片段，分别约为346、932和1217bp，其大小与预计的目的片段相符。与其他毒株的相应基因相比较，并经剪接后，TS株的sM、M和N基因全长分别为248、789和1149bp，各编码82个、262个和382个氨基酸；TS株与Purdue株、TF1株和96-1933株的sM基因核苷酸序列同源性分别为95．2％、92．7％和90．2％；推导氨基酸的同源性分别为95．9％、97．2％、98．8％；与Purdue株、TFl株、TGEVH株和96-1933株的M基因核苷酸序列同源性分别为95．2％、98．0％、99．6％和95．0％；推导氨基酸的同源性分别为97．0％、97．3％、98．5％、93．5％；与Purdue株、TF1株、FS722／70株、Korea株、TO14株、TC；EVH株和96-1933株的N基因核苷酸序列同源性分别为98．1％、97．7％、99．0％、98．3％、99．2％、99．0％和95．9％，推导氨基酸的同源性分别为97．9％、98．4％、99．0％、97．7％、99．5％、96．2％、96．6％。并对TS株基因间的保守序列和sM、M和N基因及其编码的相应氨基酸的结构特征进行了分析，发现sM和N基因在TGEV中保守；并提示在我国不仅存在有2个不同亚基因型的TGEV，而且我国的TGEV可能是输入性的。